Display options
Share it on

STAR Protoc. 2020 Oct 28;1(3):100155. doi: 10.1016/j.xpro.2020.100155. eCollection 2020 Dec 18.

Protocol for Biochemical Analysis and Structure Determination of the ZZ Domain of the E3 Ubiquitin Ligase HERC2.

STAR protocols

Jiuyang Liu, Zhaoyu Xue, Kendra R Vann, Xiaobing Shi, Tatiana G Kutateladze

Affiliations

  1. Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
  2. Center for Epigenetics, Van Andel Research Institute, Grand Rapids, MI 49503, USA.

PMID: 33377049 PMCID: PMC7757301 DOI: 10.1016/j.xpro.2020.100155

Abstract

Since its discovery, several ligands of the ZZ domain have been identified; however, molecular and structural information underlying binding of these ligands remains limited. Here, we describe a protocol for biochemical and structural analysis of the ZZ domain of human E3 ubiquitin ligase HERC2 (HERC2

© 2020 The Author(s).

Conflict of interest statement

The authors declare no competing interests.

References

  1. Nat Chem Biol. 2016 Aug 18;12(9):662-8 - PubMed
  2. Structure. 2020 Nov 3;28(11):1225-1230.e3 - PubMed
  3. Cell Rep. 2016 Oct 18;17(4):1158-1170 - PubMed
  4. Methods Enzymol. 1997;276:307-26 - PubMed
  5. J Biomol NMR. 1995 Nov;6(3):277-93 - PubMed
  6. Protein Expr Purif. 2015 Dec;116:42-9 - PubMed
  7. Protein Eng. 2001 Dec;14(12):993-1000 - PubMed
  8. Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501 - PubMed
  9. Nat Struct Mol Biol. 2018 Sep;25(9):841-849 - PubMed
  10. Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21 - PubMed
  11. Nat Struct Mol Biol. 2012 Dec;19(12):1218-27 - PubMed
  12. Nat Commun. 2018 Sep 14;9(1):3759 - PubMed
  13. Nucleic Acids Res. 2007 Jan;35(Database issue):D193-7 - PubMed
  14. Methods Enzymol. 2016;573:345-62 - PubMed

Publication Types

Grant support